Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Phase 3 Study of Adjuvant Oncophage® Versus Observation in Patients With High Risk After Surgical Treatment for Renal Cell Carcinoma

NCT00126178 is registered in ClinicalTrials.gov with Agenus Inc. as lead sponsor.

NCT NCT00126178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00126178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Phase 3 Study of Adjuvant Oncophage® Versus Observation in Patients With High Risk After Surgical Treatment for Renal Cell Carcinoma
Lead sponsor
Agenus Inc.
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2005
Completion date
March 31, 2006
Enrollment
600
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, renal cell carcinoma